Subjective complaints precede Parkinson disease: The Rotterdam study

Archives of Neurology

Volumn 63, Issue 3, 2006, Pages 362-365

  De Lau, Lonneke M L ^a   Koudstaal, Peter J ^a   Hofman, Albert ^a   Breteler, Monique M B ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BALANCE IMPAIRMENT; COHORT ANALYSIS; COMPUTER; CONFIDENCE INTERVAL; FALLING; FEMALE; FOLLOW UP; GENERAL PRACTITIONER; HAZARD ASSESSMENT; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MOTOR SYSTEM; NEUROLOGIC EXAMINATION; PARKINSON DISEASE; PARKINSONISM; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; REGRESSION ANALYSIS; RIGIDITY; RISK ASSESSMENT; TIME SERIES ANALYSIS; TREMOR;

AGED; COMMUNITY HEALTH PLANNING; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; FEMALE; HUMANS; INTERVIEWS; MALE; MIDDLE AGED; MOVEMENT DISORDERS; NEUROLOGIC EXAMINATION; PARKINSONIAN DISORDERS; PATIENT COMPLIANCE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK; TREMOR;

EID: 33644903796     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.63.3.noc50312     Document Type: Article

References (22)

1. Nussbaum RL, Ellis CE. Alzheimer's disease and Parkinson's disease. N Engl J Med. 2003;348:1356-1364.
2. Fearnley JM, Lees AJ. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain. 1991;114:2283-2301.
3. Wolters EC, Francot C, Bergmans P, et al. Preclinical (premotor) Parkinson's disease. J Neurol. 2000;247(suppl 2):II103-II109.
4. DeKosky ST, Marek K. Looking backward to move forward: early detection of neurodegenerative disorders. Science. 2003;302:830-834.
5. Ponsen MM, Stoffers D, Booij J, van Eck-Smit BL, Wolters E, Berendse HW. Idiopathic hyposmia as a preclinical sign of Parkinson's disease. Ann Neurol. 2004;56:173-181.
6. Glosser G, Clark C, Freundlich B, Kliner-Krenzel L, Flaherty P, Stern M. A controlled investigation of current and premorbid personality: characteristics of Parkinson's disease patients. Mov Disord. 1995;10:201-206.
7. Paulson GW, Dadmehr N. Is there a premorbid personality typical for Parkinson's disease? Neurology. 1991;41:73-76.
8. Leentjens AF, Van den Akker M, Metsemakers JF, Lousberg R, Verhey FR. Higher incidence of depression preceding the onset of Parkinson's disease: a register study. Mov Disord. 2003;18:414-418.
9. Gonera EG, van't Hof M, Berger HJ, van Weel C, Horstink MW. Symptoms and duration of the prodromal phase in Parkinson's disease. Mov Disord. 1997;12:871-876.
10. Hofman A, Grobbee DE, de Jong PT, van den Ouweland FA. Determinants of disease and disability in the elderly: the Rotterdam Elderly Study. Eur J Epidemiol. 1991;7:403-422.
11. de Lau LM, Schipper CMA, Hofman A, Koudstaal PJ, Breteler MMB. Prognosis of Parkinson disease: risk of dementia and mortality: the Rotterdam Study. Arch Neurol. 2005;62:1265-1269.
12. de Rijk MC, Breteler MM, Graveland GA, et al. Prevalence of Parkinson's disease in the elderly: the Rotterdam Study. Neurology. 1995;45:2143-2146.
13. de Lau LM, Giesbergen PC, de Rijk MC, Hofman A, Koudstaal PJ, Breteler MM. Incidence of parkinsonism and Parkinson disease in a general population: the Rotterdam Study. Neurology. 2004;63:1240-1244.
14. Fahn S, Elton RL; UPDRS Development Committee. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Calne DB, eds. Recent Developments in Parkinson's Disease. Vol 2. London, England: MacMillan; 1987:153-163.
15. Geerlings MI, Jonker C, Bouter LM, Ader HJ, Schmand B. Association between memory complaints and incident Alzheimer's disease in elderly people with normal baseline cognition. Am J Psychiatry. 1999;156:531-537.
16. Jorm AF, Masaki KH, Davis DG, et al. Memory complaints in nondemented men predict future pathologic diagnosis of Alzheimer disease. Neurology. 2004;63:1960-1961.
17. Jonker C, Geerlings MI, Schmand B. Are memory complaints predictive for dementia? a review of clinical and population-based studies. Int J Geriatr Psychiatry. 2000;15:983-991.
18. de Groot JC, de Leeuw FE, Oudkerk M, Hofman A, Jolles J, Breteler MM. Cerebral white matter lesions and subjective cognitive dysfunction: the Rotterdam Scan Study. Neurology. 2001;56:1539-1545.
19. Stern MB. The preclinical detection of Parkinson's disease: ready for prime time? Ann Neurol. 2004;56:169-171.
20. Michell AW, Lewis SJ, Foltynie T, Barker RA. Biomarkers and Parkinson's disease. Brain. 2004;127:1693-1705.
21. Rachakonda V, Pan TH, Le WD. Biomarkers of neurodegenerative disorders: how good are they? Cell Res. 2004;14:347-358.
22. de Rijk MC, Tzourio C, Breteler MM, et al. Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative Study, European Community Concerted Action on the Epidemiology of Parkinson's disease. J Neurol Neurosurg Psychiatry. 1997;62:10-15.